Trials / Completed
CompletedNCT02335879
Phase III Clinical Study of Domestic Recombinant Human Follitropin for Injection to Treat WHO Class II Anovulation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 534 (actual)
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd. · Industry
- Sex
- Female
- Age
- 21 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Domestic Recombinant Human Follitropin (Gonal-F) for Injection for treatment of WHO Ⅱ anovulation (including polycystic ovarian syndrome \[PCOS\] subjects).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Gonal-F |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2009-08-01
- First posted
- 2015-01-12
- Last updated
- 2015-01-12
Source: ClinicalTrials.gov record NCT02335879. Inclusion in this directory is not an endorsement.